| Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial O Trédan, Q Wang, D Pissaloux, P Cassier, A de La Fouchardière, ... Annals of Oncology 30 (5), 757-765, 2019 | 160 | 2019 |
| Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients M Manuel, O Trédan, T Bachelot, G Clapisson, A Courtier, G Parmentier, ... Oncoimmunology 1 (4), 432-440, 2012 | 141 | 2012 |
| Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases W Jacot, E Pons, JS Frenel, S Guiu, C Levy, PE Heudel, T Bachelot, ... Breast cancer research and treatment 157, 307-318, 2016 | 121 | 2016 |
| Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer J Ogier du Terrail, A Leopold, C Joly, C Béguier, M Andreux, C Maussion, ... Nature medicine 29 (1), 135-146, 2023 | 102 | 2023 |
| Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort) O Derbel, PE Heudel, C Cropet, P Meeus, G Vaz, P Biron, P Cassier, ... PloS one 12 (2), e0158406, 2017 | 99 | 2017 |
| Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors P Heudel, S Cimarelli, A Montella, C Bouteille, T Mognetti International journal of clinical oncology 15, 588-593, 2010 | 91 | 2010 |
| Brain metastases in HER2-positive breast cancer: current and novel treatment strategies A Garcia-Alvarez, A Papakonstantinou, M Oliveira Cancers 13 (12), 2927, 2021 | 86 | 2021 |
| Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group PE Heudel, M Fabbro, C Roemer-Becuwe, MC Kaminsky, A Arnaud, ... British journal of cancer 116 (3), 303-309, 2017 | 68 | 2017 |
| ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients O Tredan, C Ménétrier-Caux, I Ray-Coquard, G Garin, C Cropet, ... Annals of Oncology 26 (7), 1353-1362, 2015 | 68 | 2015 |
| Outcome of recurrent and metastatic small cell carcinoma of the bladder N Ismaili, PE Heudel, F Elkarak, W Kaikani, A Bajard, M Ismaili, H Errihani, ... BMC urology 9, 1-8, 2009 | 66 | 2009 |
| Multicenter evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic A Bizot, M Karimi, E Rassy, PE Heudel, C Levy, L Vanlemmens, C Uzan, ... British journal of cancer 125 (11), 1486-1493, 2021 | 60 | 2021 |
| Molecular characterization of anastrozole resistance in breast cancer: Pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance … P Vilquin, M Villedieu, E Grisard, SB Larbi, SE Ghayad, PE Heudel, ... International journal of cancer 133 (7), 1589-1602, 2013 | 55 | 2013 |
| Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer SI Labidi-Galy, T Olivier, M Rodrigues, D Ferraioli, O Derbel, A Bodmer, ... Clinical Cancer Research 24 (2), 326-333, 2018 | 52 | 2018 |
| Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region PE Heudel, P Cousin, A Lurkin, C Cropet, F Ducimetiere, O Collard, ... International journal of clinical oncology 19, 744-752, 2014 | 49 | 2014 |
| Effect of weekly paclitaxel with or without bevacizumab on progression-free rate among patients with relapsed ovarian sex cord-stromal tumors: the ALIENOR/ENGOT-ov7 randomized … I Ray-Coquard, P Harter, D Lorusso, C Dalban, I Vergote, K Fujiwara, ... JAMA oncology 6 (12), 1923-1930, 2020 | 45 | 2020 |
| Small cell cancer of the bladder: The Leon-Berard cancer centre experience N Ismaili, F Elkarak, PE Heudel, A Flechon, JP Droz Indian Journal of Urology 24 (4), 494-497, 2008 | 44 | 2008 |
| Feasibility and health benefits of an individualized physical activity intervention in women with metastatic breast cancer: intervention study L Delrieu, V Pialoux, O Pérol, M Morelle, A Martin, C Friedenreich, ... JMIR mHealth and uHealth 8 (1), e12306, 2020 | 42 | 2020 |
| Micropapillary bladder cancer: a review of Leon Berard Cancer Center experience P Heudel, F El Karak, N Ismaili, JP Droz, A Flechon BMC urology 9, 1-5, 2009 | 42 | 2009 |
| Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor− Positive Recurrent or Metastatic Endometrial Cancer: The … P Heudel, JS Frenel, C Dalban, F Bazan, F Joly, A Arnaud, C Abdeddaim, ... JAMA oncology 8 (7), 1001-1009, 2022 | 41 | 2022 |
| Impact of body mass index on overall survival in patients with metastatic breast cancer K Saleh, M Carton, V Dieras, PE Heudel, E Brain, V D’hondt, A Mailliez, ... The Breast 55, 16-24, 2021 | 38 | 2021 |
